Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triglyceride-glucose index and its derived anthropometric indices: a comparative analysis for mortality prediction in the population cohort of the URRAH study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

[2025 AHA/ACC Guidelines on hypertension: what are the main novelties?]

Giornale italiano di cardiologia (2006)·2026
Same author

Refining the impact of epicardial adipose tissue assessment.

European journal of internal medicine·2026
Same author

Should we really target a higher blood pressure in the presence of left ventricular hypertrophy?

European journal of internal medicine·2026
Same author

The Relation Between Blood Pressure and Outcomes in Diabetes: With or Without the J Curve?

Journal of the American College of Cardiology·2026
Same author

Should systolic pressure be lowered in isolated diastolic hypertension?

European heart journal·2025

Related Experiment Videos

Fixed-dose combination therapy in hypertension: cons.

Fabio Angeli1, Gianpaolo Reboldi, Giovanni Mazzotta

  • 1Section of Cardiology, Hospital Media Valle del Tevere, Umbria, Perugia, Italy. fangeli@cardionet.it

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|August 8, 2012
PubMed
Summary

Fixed-dose combination pills simplify hypertension treatment but may lack flexibility. New tablet designs aim to improve dosing adjustments and patient outcomes in blood pressure management.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Antihypertensive therapy aims to reduce risks from elevated blood pressure.
  • Blood pressure reduction is the primary factor in cardiovascular prevention.
  • Many patients require multiple medications for effective blood pressure control.

Purpose of the Study:

  • To evaluate the clinical utility of fixed-dose combination antihypertensive pills.
  • To compare the benefits of fixed combinations versus separate component administration.
  • To assess the impact of fixed combinations on blood pressure control and cardiovascular prevention.

Main Methods:

  • Review of randomized clinical trials and meta-analyses on antihypertensive therapies.
  • Analysis of existing literature on fixed-dose combination pills for hypertension.
  • Examination of proposed novel fixed-dose tablet designs for improved flexibility.

Main Results:

  • Blood pressure reduction itself is the key determinant of cardiovascular risk reduction.
  • Fixed-dose combinations can simplify regimens and improve adherence.
  • Current fixed-dose pills lack flexibility in dose titration and component adjustment, potentially leading to suboptimal outcomes or side effects.

Conclusions:

  • While fixed-dose combinations offer convenience, their inflexibility is a significant drawback.
  • Novel tablet designs with enhanced flexibility are needed to optimize antihypertensive therapy.
  • Improved fixed-dose formulations could enhance blood pressure control and cardiovascular prevention in clinical practice.